Skip to content
Events

Details

Hear from Steve Barnard about the latest Illumina innovations from library prep, sequencing, and analysis and learn how we are enabling transformative applications using multiomics. Niall Lennon, PhD from the Broad Institute of MIT will join Steve to provide insights into new Illumina technology.
Steve Barnard, PhD

Steve Barnard, PhD
Chief Technology Officer
Illumina

Steve Barnard, PhD

Niall Lennon, PhD
Chair and Chief Scientific Officer
Broad Clinical Labs, MIT

 

M-AMR-01684
Fill Out Form to Access Webinar
Date & Time
6 Nov 2024
Topic
Instruments, Software & informatics
Watch Now

Related Events

Jul 8
Understanding and Optimizing Loading Concentration for Patterned Flow Cells
8 Jul 2026
Learn the essentials of loading concentration and optimization for patterned flow cells, and dive into the use of titration runs.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.